Cognitive Effects of Immunomodulatory Drugs in MS
Cognitive Effects of Immunomodulatory Drugs in MS
The purpose of this study is to examine and compare changes in the specific thinking skills
 of patients with RRMS who are receiving treatment with one of three immunomodulatory
 medications (Avonex, Copaxone, or Rebif).
In addition this study will compare the patients' personal view of how they are doing, any
 changes in physical disability, and the frequency and severity of relapses over the three
 year period.
Inclusion Criteria:

 -  Diagnosis of RRMS for at least one year,

 -  Currently on one of three immunomodulatory drugs (Avonex, Copaxone, or Rebif),

 -  Visual Acuity is 20/50 or better,

 -  patient has four color vision,

 -  Must have at least a high school education

 Exclusion Criteria:

 -  History of head injury, drug/alcohol abuse, and/or psychiatric problems, -current
 diagnosis of a severe or lifethreatening disease other than MS,

 -  currently taking immunosuppressant medication,

 -  resides greater than 200 miles from the study site